– Aiming to Realize 3 Zeros: “Zero Cerebrovascular and Cardiovascular Events,” “Zero Aggravation of Respiratory Diseases” and “Zero Restrictions on Daily Activities Due to Chronic Pain” – KYOTO, Japan, May 10, 2022 /PRNewswire/ — In March 2022, OMRON Group announced a new long-term vision, “Shaping the Future 2030” (hereafter referred to as SF2030). In its commitment […]
Rhythm
Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH
PARIS, May 09, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat hypertension and heart failure, announces today that it has recruited all planned patients in its phase III pivotal study FRESH, […]
OMRON Healthcare Issues National Health Alert: Pandemic-Driven Trends Are Raising Heart Health Risks
Global heart health leader urges Americans to monitor blood pressure regularly and take action to manage hypertension among increased health risks associated with COVID-19 pandemic HOFFMAN ESTATES, Ill., May 5, 2022 /PRNewswire/ — Global heart health leader,, today issued a national health alert warning of increased heart health risks emerging from the […]
Eko Recognized with Second Consecutive MedTech Breakthrough Award for AI Innovation in Healthcare
Point-of-care cardiac screening solution honored at sixth annual awards program for improving detection of heart disease OAKLAND, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Eko, a digital health company advancing heart and lung disease detection, today announced that, for the second consecutive year, it has won the “Best Use of Artificial […]
CathVision Announces FDA Clearance of ECGenius™ High-Fidelity, Low-Noise EP Recording Technology
ECGenius Sets a New Standard for ECG Signal Detection, Interpretation and Therapy Support COPENHAGEN, Denmark , May 4, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the FDA 510(k) clearance of the ECGenius EP Recording System. ECGenius, the […]
3M Littmann CORE Digital Stethoscope Honored in Fast Company’s 2022 World Changing Ideas Awards
ST. PAUL, Minn., May 3, 2022 /PRNewswire/ — 3M™ Littmann® today announced its 3M™ Littmann® CORE Digital Stethoscope received honorable mention accolades in the health category of the 2022 Fast Company World Changing Ideas global awards program recognizing companies, products and initiatives that support innovation for the public good and tackle social inequality, climate change and public health […]
Heart Centre Rigshospitalet Copenhagen Celebrates 5,000 Robotic Cardiac Ablation Procedures
Denmark’s only robotic cardiac electrophysiology team is recognized for leading the world in treating the most heart rhythm patients using Stereotaxis’ advanced robotic technology ST. LOUIS, May 04, 2022 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, celebrates the achievements of the […]
AliveCor Launches KardiaComplete to Help Reduce the Rising Health and Economic Costs of Heart Disease
Pairs proven AI-driven remote personal monitoring solutions with easy-to-access services and virtual cardiologist visits to help improve outcomes and reduce cost of care MOUNTAIN VIEW, Calif., May 3, 2022 /PRNewswire/ — AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of KardiaComplete, a comprehensive heart health enterprise solution […]
Vivalink Announces World’s First Multi-Vital Blood Pressure Patch for Remote Patient Monitoring
Integrated patch offers ECG, heart rate, respiratory rate, and blood pressure monitoring for commercial research and development Campbell, Calif. – May 3, 2022 – Vivalink, a leading provider of digital healthcare solutions, announces availability of the world’s first multi-vital blood pressure patch for remote patient monitoring for use in commercial […]
Xcardia Announces First-In-Human Use of its New Xtractor Device for Cardiac Pacemaker and Defibrillator Lead Extraction Procedures
Announcement Follows FDA 510(k) Clearance of Device REHOVOT, Israel, April 29, 2022 /PRNewswire/ — Today, Xcardia Innovation Ltd., a private medical device company developing innovative cardiac pacemaker and defibrillator technology, announced the first-in-human use of its new Xtractor device in patients undergoing lead extraction procedures. Charles J. Love MD, Director, Cardiac Rhythm Device Services and […]


